Prevduo Injection
Product Images NDC 42023-269

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Prevduo (NDC 42023-269). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Endo Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Glyco-structure (Glyco Structure)

Chemical structure of neostigmine methylsulfate, the active ingredient in PREVDUO injection by Endo USA. The diagram shows the molecular arrangement including the phenyl group, ester linkage, and quaternary ammonium group associated with neostigmine methylsulfate.*

FDA Label Image

Ifu-1 (Ifu 1)

An instructional diagram of a syringe with labeled parts including a removable syringe tip cap and a plastic wrap advising not to remove it. The syringe barrel is marked with volume measurements from 0.5 mL to 3 mL, suitable for precise dosing.*

FDA Label Image

Ifu-2 (Ifu 2)

An instructional diagram depicting the opening of a folding box to reveal a blister pack containing six round tablets arranged in two rows of three. An arrow points outward from the box, indicating removal of the blister pack.*

FDA Label Image

Ifu-3 (Ifu 3)

An instructional illustration showing two hands preparing a prefilled syringe for injection. One hand holds the syringe barrel, while the other hand twists to remove the cap from the syringe needle. This depicts a step in the preparation of an intravenous injection.*

FDA Label Image

Neo-structure (Neo Structure)

Chemical structure of neostigmine methylsulfate, the active ingredient in PREVDUO injection. The diagram shows the molecular arrangement including the quaternary ammonium group, aromatic ring, carbamate group, and methyl sulfate anion.*

FDA Label Image

N+g Container Label (Ng Container)

Label for PREVDUO injection containing neostigmine methylsulfate 3 mg/3 mL (1 mg/mL) and glycopyrrolate 0.6 mg/3 mL (0.2 mg/mL) in a 3 mL single-dose prefilled syringe for intravenous use. The label includes volume graduations from 0.5 to 3 mL, barcode, lot and expiration date fields, and states Rx only. Manufactured by Endo USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.